About This Fund
Hoxton Ventures III is the third flagship early-stage venture capital fund managed by London-based Hoxton Ventures, having reached a final close of $215 million in March 2022 — significantly exceeding its original target of $150 million and marking a 43% oversubscription. The fund was established to capitalize on the continued maturation of the European technology ecosystem and the increasing readiness of European founders to build companies with global scale.
The fund employs a seed-stage investment strategy focused on European technology startups with explicit ambitions to expand into the United States market. Hoxton Ventures III typically writes initial checks ranging from $500,000 to $5 million across enterprise software, marketplace, consumer technology, and deeptech companies. The partnership team, expanded with the addition of Charles Seely as equal partner for this vehicle, takes a concentrated approach — seeking to back category-defining companies at their earliest stage rather than broad portfolio diversification.
Hoxton Ventures' track record across its earlier funds — Hoxton I and Hoxton II — laid the foundation for Fund III with notable portfolio outcomes including Deliveroo (London Stock Exchange IPO), Darktrace (London Stock Exchange IPO), and Babylon Health. As of its latest reporting, Hoxton Ventures III has deployed capital across 19 portfolio companies from a total firm portfolio of over 63 investments, with four portfolio companies having achieved valuations exceeding $1 billion. The most recent disclosed investment from the fund was made in June 2024 in Fabrica AI.